A Phase 1 Study of BHV-1530 in Advanced Solid Tumors
Public ClinicalTrials.gov record NCT06874335. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1, Multicenter, Open-Label, Dose Escalation, Dose Expansion and Dose Confirmation Study of BHV-1530 in Adult Patients With Advanced or Metastatic Solid Tumors
Study identification
- NCT ID
- NCT06874335
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Biohaven Therapeutics Ltd.
- Industry
- Enrollment
- 95 participants
Conditions and interventions
Conditions
Interventions
- BHV-1530 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 19, 2025
- Primary completion
- Feb 28, 2029
- Completion
- Feb 28, 2029
- Last update posted
- May 12, 2026
2025 – 2029
United States locations
- U.S. sites
- 13
- U.S. states
- 9
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site-107 | Denver | Colorado | 80218 | Recruiting |
| Site-108 | Lake Mary | Florida | 32746 | Withdrawn |
| Site-121 | Miami | Florida | 33136 | Recruiting |
| Site-110 | Detroit | Michigan | 48201 | Recruiting |
| Site-115 | Durham | North Carolina | 27710 | Recruiting |
| Site-112 | Myrtle Beach | South Carolina | 29572 | Recruiting |
| Site-116 | Nashville | Tennessee | 37203 | Recruiting |
| Site-103 | Austin | Texas | 78758 | Recruiting |
| Site-104 | Houston | Texas | 77030 | Recruiting |
| Site-101 | Irving | Texas | 75039 | Recruiting |
| Site-105 | San Antonio | Texas | 78229 | Recruiting |
| Site-106 | West Valley City | Utah | 84119 | Recruiting |
| Site-102 | Fairfax | Virginia | 22031 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06874335, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 12, 2026 · Synced May 16, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06874335 live on ClinicalTrials.gov.